Cargando…
The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells
Extracellular vesicles (EVs) are ideal for liquid biopsy, but distinguishing cancer cell‐derived EVs and subpopulations of biomarker‐containing EVs in body fluids has been challenging. Here, we identified that the glycoproteins CD147 and CD98 define subpopulations of EVs that are distinct from class...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042814/ https://www.ncbi.nlm.nih.gov/pubmed/36973758 http://dx.doi.org/10.1002/jev2.12318 |
_version_ | 1784913014322888704 |
---|---|
author | Ko, Song Yi Lee, WonJae Weigert, Melanie Jonasch, Eric Lengyel, Ernst Naora, Honami |
author_facet | Ko, Song Yi Lee, WonJae Weigert, Melanie Jonasch, Eric Lengyel, Ernst Naora, Honami |
author_sort | Ko, Song Yi |
collection | PubMed |
description | Extracellular vesicles (EVs) are ideal for liquid biopsy, but distinguishing cancer cell‐derived EVs and subpopulations of biomarker‐containing EVs in body fluids has been challenging. Here, we identified that the glycoproteins CD147 and CD98 define subpopulations of EVs that are distinct from classical tetraspanin(+) EVs in their biogenesis. Notably, we identified that CD147(+) EVs have substantially higher microRNA (miRNA) content than tetraspanin(+) EVs and are selectively enriched in miRNA through the interaction of CD147 with heterogeneous nuclear ribonucleoprotein A2/B1. Studies using mouse xenograft models showed that CD147(+) EVs predominantly derive from cancer cells, whereas the majority of tetraspanin(+) EVs are not of cancer cell origin. Circulating CD147(+) EVs, but not tetraspanin(+) EVs, were significantly increased in prevalence in patients with ovarian and renal cancers as compared to healthy individuals and patients with benign conditions. Furthermore, we found that isolating miRNAs from body fluids by CD147 immunocapture increases the sensitivity of detecting cancer cell‐specific miRNAs, and that circulating miRNAs isolated by CD147 immunocapture more closely reflect the tumor miRNA signature than circulating miRNAs isolated by conventional methods. Collectively, our findings reveal that CD147 defines miRNA‐enriched, cancer cell‐derived EVs, and that CD147 immunocapture could be an effective approach to isolate cancer‐derived miRNAs for liquid biopsy. |
format | Online Article Text |
id | pubmed-10042814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100428142023-03-29 The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells Ko, Song Yi Lee, WonJae Weigert, Melanie Jonasch, Eric Lengyel, Ernst Naora, Honami J Extracell Vesicles Research Articles Extracellular vesicles (EVs) are ideal for liquid biopsy, but distinguishing cancer cell‐derived EVs and subpopulations of biomarker‐containing EVs in body fluids has been challenging. Here, we identified that the glycoproteins CD147 and CD98 define subpopulations of EVs that are distinct from classical tetraspanin(+) EVs in their biogenesis. Notably, we identified that CD147(+) EVs have substantially higher microRNA (miRNA) content than tetraspanin(+) EVs and are selectively enriched in miRNA through the interaction of CD147 with heterogeneous nuclear ribonucleoprotein A2/B1. Studies using mouse xenograft models showed that CD147(+) EVs predominantly derive from cancer cells, whereas the majority of tetraspanin(+) EVs are not of cancer cell origin. Circulating CD147(+) EVs, but not tetraspanin(+) EVs, were significantly increased in prevalence in patients with ovarian and renal cancers as compared to healthy individuals and patients with benign conditions. Furthermore, we found that isolating miRNAs from body fluids by CD147 immunocapture increases the sensitivity of detecting cancer cell‐specific miRNAs, and that circulating miRNAs isolated by CD147 immunocapture more closely reflect the tumor miRNA signature than circulating miRNAs isolated by conventional methods. Collectively, our findings reveal that CD147 defines miRNA‐enriched, cancer cell‐derived EVs, and that CD147 immunocapture could be an effective approach to isolate cancer‐derived miRNAs for liquid biopsy. John Wiley and Sons Inc. 2023-03-27 2023-04 /pmc/articles/PMC10042814/ /pubmed/36973758 http://dx.doi.org/10.1002/jev2.12318 Text en © 2023 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Ko, Song Yi Lee, WonJae Weigert, Melanie Jonasch, Eric Lengyel, Ernst Naora, Honami The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells |
title | The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells |
title_full | The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells |
title_fullStr | The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells |
title_full_unstemmed | The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells |
title_short | The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells |
title_sort | glycoprotein cd147 defines mirna‐enriched extracellular vesicles that derive from cancer cells |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042814/ https://www.ncbi.nlm.nih.gov/pubmed/36973758 http://dx.doi.org/10.1002/jev2.12318 |
work_keys_str_mv | AT kosongyi theglycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT leewonjae theglycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT weigertmelanie theglycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT jonascheric theglycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT lengyelernst theglycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT naorahonami theglycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT kosongyi glycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT leewonjae glycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT weigertmelanie glycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT jonascheric glycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT lengyelernst glycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells AT naorahonami glycoproteincd147definesmirnaenrichedextracellularvesiclesthatderivefromcancercells |